Elsevier Offers First Consult Users Anywhere, Anytime Access Through New Apple iPhone App

By Elsevier, PRNE
Monday, November 15, 2010

New iPhone App Gives Clinicians, Students and Others Access to Trusted, Quick, On-Demand Answers From First Consult, Without a Data Connection

NEW YORK, November 16, 2010 - Elsevier, (www.elsevier.com/) the
leading publisher of scientific, technical and medical information products
and services, today announced the availability of an iPhone App that gives
whenever, wherever access to users of First Consult,
(www.firstconsult.com/) an online
clinical information resource that delivers quick, trusted answers to
clinical questions at the point-of-care. The app is available as a free
download from the Apple App Store (
info.firstconsult.com/iphone-app.html) and works on Apple's iPhone,
iPad, and iPod Touch devices. Access is available to all First Consult
individual and institutional subscribers as part of the subscription for no
additional charge. Free 60-day trial evaluations are also available.

Individuals who download the app by January 31, 2011, automatically are
entered into a drawing to win an iPad. In addition, the institution with the
most downloads of the app by the same date will be awarded an iPad for
library use.

Developed in partnership with the mobility team within the Information
Services practice at Infosys, (www.infosys.com/) the
new First Consult App supports physicians, residents and medical students who
may lack an immediate data connection within a hospital, office or medical
school but who still need instant, user-friendly access to the latest
information on patient evaluation, diagnosis, clinical management, prognosis,
and prevention from First Consult.

"iPhone access to First Consult fulfills Elsevier's commitment to provide
clinicians with on-demand access to accurate, evidence-based and actionable
information when and where it's needed in the healthcare workflow," said
Chris Dillon, Managing Director for Clinical Decision Support at Elsevier
Health Sciences. "Our mobile app will be indispensable in helping clinicians
throughout the world reduce risks for medical errors, adverse drug events and
extended lengths of stay."

In addition to offering clinicians anytime/anywhere access to clinical
content, the First Consult iPhone App saves time thanks to its easy-to-use,
easy-to-learn navigation. Because data is stored on the mobile device,
clinicians no longer need to wait for data pages to load.

"The new First Consult App is a convenient, easy-to-use, time-saving tool
for busy clinicians who need a fast, trusted answer on a patient question,
wherever they are and whenever they need it-whether in the hospital, the
office, at home or in the car," said Jonathan Teich M.D., Chief Medical
Informatics Officer, Elsevier. "It enables better decision-making because
clinicians can be confident that they've received the best, most regularly
updated information on patient evaluation, diagnosis, treatment, tests and

The release of the First Consult iPhone App coincides with physicians'
growing interest in mobile devices. Sixty-four percent of physicians owned
smartphones in 2009, a figure that is expected to reach 81 percent by 2012,
according to Manhattan Research. (www.manhattanresearch.com/)
Moreover, 94 percent of physicians who own smartphones use them to
communicate, manage personal and business workflows, and access medical
information, says a 2010 survey from Spyglass Consulting Group.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and
medical information products and services. The company works in partnership
with the global science and health communities to publish more than 2,000
journals, including The Lancet (www.thelancet.com) and Cell
(www.cell.com), and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier's online solutions include
SciVerse ScienceDirect (www.sciencedirect.com), SciVerse Scopus
(www.scopus.com), Reaxys (www.reaxys.com), MD Consult
(www.mdconsult.com) and Nursing Consult (www.nursingconsult.com
), which enhance the productivity of science and health professionals, and
the SciVal suite (www.scival.com) and MEDai's Pinpoint Review
(www.medai.com), which help research and health care institutions
deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier (
www.elsevier.com) employs 7,000 people worldwide. The company is part
of Reed Elsevier Group PLC (www.reedelsevier.com), a world-leading
publisher and information provider, which is jointly owned by Reed Elsevier
PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam),
REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

    Media Contact

    Tom Reller
    Vice President of Global Relations, Elsevier

Media Contact: Tom Reller, Vice President of Global Relations, Elsevier, +1-212-462-1912, T.Reller at Elsevier.com

will not be displayed